ARANESP HSA-FREE. 40MCG/0.4ML SINGLE-USE PREFILLED SYRINGES (Darbépoétine alfa) est un médicament commercialisé au Canada. Retrouvez ici composition, équivalents.
| Substance | Dosage | Pour |
|---|---|---|
| Darbépoétine alfa | 100 µg | — |
| Nom commercial | Dosage | Forme | Prix | P/G |
|---|---|---|---|---|
| ARANESP HSA-FREE. 200 MCG/0.4 ML SINGLE-USE PREFILLED SYRINGES (SINGLEJECT) | 500 µg | Solution | — | — |
| ARANESP HSA-FREE. 50 MCG/0.5 ML SINGLE-USE PREFILLED SYRINGES (SINGLEJECT) | 100 µg | Solution | — | — |
| ARANESP HSA-FREE. 500 MCG/1 ML SINGLE-USE PREFILLED SYRINGES (SINGLEJECT) | 500 µg | Solution | — | — |
| ARANESP HSA-FREE. 300 MCG/0.6 ML SINGLE-USE PREFILLED SYRINGES (SINGLEJECT) | 500 µg | Solution | — | — |
| ARANESP HSA-FREE. 80 MCGG/0.4 ML SINGLE-USE PREFILLED SYRINGES (SINGLEJECT) | 200 µg | Solution | — | — |
| ARANESP (HSA-FREE) - 10 MCG/0.4 ML SINGLE-USE PREFILLED SYRINGES (SINGLEJECT) | 25 µg | Solution | — | — |
| ARANESP HSA-FREE. 100 MCG/0.5 ML SINGLE-USE PREFILLED SYRINGES (SINGLEJECT) | 200 µg | Solution | — | — |
| ARANESP HSA-FREE. 20 MCG/0.5ML SINGLE-USE PREFILLED SYRINGES (SINGLEJECT) | 40 µg | Solution | — | — |
| ARANESP HSA-FREE. 130 MCG/0.65 ML SINGLE-USE PREFILLED SYRINGES (SINGLEJECT) | 200 µg | Solution | — | — |
| ARANESP HSA-FREE. 30 MCG/0.3 ML SINGLE-USE PREFILLED SYRINGES (SINGLEJECT) | 100 µg | Solution | — | — |
| ARANESP HSA-FREE. 150 MCG/0.3 ML SINGLE-USE PREFILLED SYRINGES (SINGLEJECT) | 500 µg | Solution | — | — |
| ARANESP HSA-FREE. 60 MCG/0.3 ML SINGLE-USE PREFILLED SYRINGES (SINGLEJECT) | 200 µg | Solution | — | — |
Non. Le registre national classe ARANESP HSA-FREE. 40MCG/0.4ML SINGLE-USE PREFILLED SYRINGES parmi les médicaments soumis à prescription médicale : une ordonnance est exigée pour sa délivrance.
Oui : 12 médicaments commercialisés au Canada contiennent la même substance active.
La classe pharmacothérapeutique de ARANESP HSA-FREE. 40MCG/0.4ML SINGLE-USE PREFILLED SYRINGES est identifiée par son code ATC. Son code ATC est B03XA02.